Orostachys japonicus induces apoptosis and cell cycle arrest through the mitochondria-dependent apoptotic pathway in AGS human gastric cancer cells

International Journal of Oncology

Volumn 45, Issue 1, 2014, Pages 459-469

  Ryu, Deok Seon ^a   Kim, Seon Hee ^a   Kwon, Ji Hae ^a   Lee, Dong Seok ^a  

^a Inje University   (South Korea)

Author keywords

AGS human gastric cancer cells apoptosis; Cell cycle arrest; MAPKs; Orostachys japonicus

Indexed keywords

ACETIC ACID ETHYL ESTER; CASPASE 3; CASPASE 8; CASPASE 9; CYCLIN B1; CYCLIN DEPENDENT KINASE 1; CYSTEINE PROTEINASE INHIBITOR; CYTOCHROME C; MITOGEN ACTIVATED PROTEIN KINASE P38; OROSTACHYS JAPONICUS EXTRACT; PLANT EXTRACT; PROCASPASE 3; PROCASPASE 8; PROCASPASE 9; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG; ACETIC ACID DERIVATIVE; ANTINEOPLASTIC AGENT;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL COUNT; CELL CYCLE ARREST; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG MECHANISM; ENZYME PHOSPHORYLATION; FLOW CYTOMETRY; G2 PHASE CELL CYCLE CHECKPOINT; GASTRIC CANCER CELL LINE; HUMAN; HUMAN CELL; M PHASE CELL CYCLE CHECKPOINT; MEDICINAL PLANT; MITOCHONDRION; OROSTACHYS JAPONICUS; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; CELL CYCLE CHECKPOINT; CHEMISTRY; CRASSULACEAE; DOSE RESPONSE; DRUG EFFECTS; GENE EXPRESSION REGULATION; PATHOLOGY; PHOSPHORYLATION; SIGNAL TRANSDUCTION; STOMACH TUMOR; TUMOR CELL LINE;

ACETATES; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL CYCLE CHECKPOINTS; CELL LINE, TUMOR; CRASSULACEAE; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; PHOSPHORYLATION; PLANT EXTRACTS; SIGNAL TRANSDUCTION; STOMACH NEOPLASMS;

EID: 84902583274     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2014.2404     Document Type: Article

References (51)

1. Kelloff GJ: Perspectives on cancer chemoprevention research and drug development. Adv in Cancer Res 78: 199-334, 2000.
2. Ryu DS, Baek GO, Kim EY, Kim KH and Lee DS: Effects of polysaccharides derived from Orostachys japonicus on induction of cell cycle arrest and apoptotic cell death in human colon cancer cells. BMB Rep 43: 750-755, 2010.
3. Choi SY, Chung MJ, Seo WD, Shin JH, Shon MY and Sung NJ: Inhibitory effects of Orostachys japonicus extracts on the formation of N-nitrosodimethylamine. J Agric Food Chem 54: 6075-6078, 2006.
4. Jung HJ, Choi J, Nam JH and Park HJ: Anti-ulcerogenic effects of the flavonoid-rich fraction from the extract of Orostachys japonicus in mice. J Med Food 10: 702-706, 2007.
5. Lee HS, Ryu DS, Lee GS and Lee DS: Anti-inflammatory effects of dichloromethane fraction from Orostachys japonicus in RAW 264.7 cells: Suppression of NF-ΚB activation and MAPK signaling. J Ethnopharmacol 140: 271-276, 2012.
6. Je Ma C, Jung WJ, Lee KY, Kim YC and Sung SH: Calpain inhibitory flavonoids isolated from Orostachys japonicus. J Enzyme Inhib Med Chem 24: 676-679, 2009.
7. Park HJ, Young HS, Park KY, Rhee SH, Chung HY and Choi JS: Flavonoids from the whole plants of Orostachys japonicus. Arch Pharm Res 14: 167-171, 1991.
8. Ryu DS, Lee HS, Lee GS and Lee DS: Effect of the ethylacetate extract of Orostachys japonicus on induction of apoptosis through the p53-mediated signaling pathway in human gastric cancer cells. Biol Pharm Bull 35: 660-665, 2012.
9. Singh SV, Herman-Antosiewicz A, Singh AV, Lew KL, Srivastava SK, Kamath R, Brown KD, Zhang L and Baskarah R: Sulforaphane-induced G2/M phase cell cycle arrest involves checkpoint kinase 2-mediated phosphorylation of cell division cycle 25C. J Biol Chem 279: 25813-25822, 2004.
10. Harris SL and Levin AJ: The p53 pathway: positive and negative feedback loops. Oncogene 24: 2899-2908, 2005.
11. Vazquez A, Bond EE, Levine AJ and Bond GL: The genetics of the p53 pathway, apoptosis and cancer therapy. Nat Rev Drug Discov 7: 979-987, 2008.
12. Shiozaki EN and Shi Y: Caspases, IAPs and Smac/DIABLO: mechanisms from structural biology. Trends Biochem Sci 29: 486-494, 2004.
13. Tsujimoto Y: Bcl-2 family of proteins: life-or-death switch in mitochondria. Biosci Rep 22: 47-58, 2002.
14. Dhanalakshmi S, Agarwal P, Globe L and Agarwal R: Silibinin sensitizes human prostate carcinoma DU145 cells to cisplatinand carboplatin-induced growth inhibition and apoptotic death. Int J Cancer 106: 699-705, 2003.
15. Brooks G: Cyclin, cyclin-dependent kinases, and cyclindependent kinase inhibitors: detection methods and activity measurements. Methods Mol Biol 296: 291-298, 2005.
16. Vermeulen K, Berneman ZN and Van Bockstaele DR: Cell cycle and apoptosis. Cell Prolif 36: 165-175, 2003.
17. Sebolt-Leopold JS: Development of anticancer drugs targeting the MAP kinase pathway. Oncogene 19: 6594-6599, 2000.
18. Sebolt-Leopold JS and Herrera R: Targeting the mitogenactivated protein kinase cascade to treat cancer. Nat Rev Cancer 4: 937-947, 2004.
19. Jeong JH, Ryu DS, Suk DH and Lee DS: Anti-inflammatory effects of ethanol extract from Orostachys japonicus on modulation of signal pathways in LPS-stimulated RAW 264.7 cells. BMB Rep 44: 399-404, 2011.
20. Lee HS, Bilehal D, Lee GS, Ryu DS, Kim HK, Suk DH and Lee DS: Anti-inflammatory effect of the hexane fraction from Orostachys japonicus in RAW 264.7 cells by suppression of NF-ΚB and PI3K-Akt signaling. J Funct Foods 5: 1217-1225, 2013.
21. Kaufmann SH and Henqartner MO: Programmed cell death: alive and well in the new millennium. Trends Cell Biol 11: 526-534, 2001.
22. Ryu DS, Kim SH and Lee DS: Anti-proliferative effect of polysaccharides from Salicornia herbacea on induction of G2/M arrest and apoptosis in human colon cancer cells. J Microbiol Biotechnol 19: 1482-1489, 2009.
23. Nakanishi M, Shimada N and Niida H: Genetic instability in cancer cells by impaired cell cycle checkpoints. Cancer Sci 97: 984-989, 2006.
24. Elledge SJ and Harpae JW: CDK inhibitors; on the threshold of checkpoints and development. Curr Opin Cell Biol 6: 847-852, 1994.
25. Vousden KH: Apoptosis. p53 and PUMA: a deadly duo. Science 309: 1685-1686, 2005.
26. Lavin MF and Gueven N: The complexity of p53 stabilization and activation. Cell Death Differ 13: 941-950, 2006.
27. Ai Z, Lu W and Qin X: Arsenic trioxide induces gallbladder carcinoma cell apoptosis via down regulation of bcl-2. Biochem Biophys Res Commun 348: 1075-1081, 2006.
28. Wang JB, QI LL, Zheng SD and Wu TX: Curcumin induces apoptosis through the mitochondria-mediated apoptotic pathway in HT-29 cells. J Zhejizng Univ Sci B 10: 93-102, 2009.
29. Lavrik I, Golks A and Krammer PH: Death receptor signaling. J Cell Sci 118: 265-267, 2005.
30. Fujita E, Egashira J, Urase K, Kuida K and Momoi T: Caspase-9 processing by caspase-3 via a feedback amplification loop in vivo. Cell Death Differ 8: 335-344, 2001.
31. Seger R and Krebs EG: The MAPK signaling cascade. FASEB J 9: 726-735, 1995.
32. Meier P, Finch A and Evan G: Apoptosis in development. Nature 407: 796-801, 2000.
33. Evan GI and Vousden KH: Proliferation, cell cycle and apoptosis in cancer. Nature 411: 342-348, 2001.
34. Schwartz GK and Shah MA: Targeting the cell cycle: a new approach to cancer therapy. J Clin Oncol 23: 9408-9421, 2005.
35. Koff A, Giordano A, Desai D, Yamashita K, Harper JW, Elledge S, Nishimoto T, Morgan DO, Franza BR and Roberts JM: Formation and activation of a cyclin E-cdk2 complex during the G1 phase of the human cell cycle. Science 257: 1689-1694, 1992.
36. Fisher DE: The p53 tumor suppressor: critical regulator of life & death in cancer. Apoptosis 6: 7-15, 2001.
37. Moll UM and Zaika A: Nuclear and mitochondrial apoptotic pathways of p53. FEBS Lett 493: 65-69, 2001.
38. Erster S, Mihara M, Kim RH, Petrenko O and Moll UM: In vivo mitochondrial p53 translocation triggers a rapid first wave of cell death in response to DNA damage that can precede p53 target gene activation. Mol Cell Biol 24: 6728-6741, 2004.
39. Jiang X and Wang X: Cytochrome c-mediated apoptosis. Annu Rev Biochem 73: 87-106, 2004.
40. Nagata S: Fas ligand-induced apoptosis. Annu Rev Genet 33: 29-55, 1999.
41. Willis SN and Adams JM: Life in the balance: how BH3-only proteins induce apoptosis. Curr Opin Cell Biol 17: 617-625, 2005.
42. Pop C, Timmer J, Sperandio S and Salvesen GS: The apoptosome activates caspase-9 by dimerization. Mol Cell 22: 269-275, 2006.
43. Zhou Z, Sun X and Kang YJ: Ethanol-induced apoptosis in mouse liver: Fas- and cytochrome c-mediated caspase-3 activation pathway. Am J Pathol 159: 329-338, 2001.
44. Jin UH, Song KH, Motomura M, Suzuki I, Gu YH, Kang YJ, Moon TC and Kim CH: Caffeic acid phenethyl ester induces mitochondria-mediated apoptosis in human myeloid leukemia U937 cells. Mol Cell Biochem 310: 43-48, 2008.
45. Zheng Y, Zhou M, Ye A, Li Q, Bai Y and Zhang Q: The conformation change of Bcl-2 is involved in arsenic trioxide-induced apoptosis and inhibition of proliferation in SGC7901 human gastric cancer cells. World J Sur Oncol 8: 31, 2010.
46. Cho SH, Chung KS, Choi JH, Kim DH and Lee KT: Compound K, a metabolite of ginseng saponin, induces apoptosis via caspase- 8-dependent pathway in HL-60 human leukemia cells. BMC Cancer 9: 449, 2009.
47. Martin GS: Cell signaling and cancer. Cancer Cell 4: 167-174, 2003.
48. Freeman SM and Whartenby KA: The role of the mitogenactivated protein kinase cellular signaling pathway in tumor cell survival and apoptosis. Drug News Perspect 17: 237-242, 2004.
49. Lin A and Dibling B: The true face of JNK activation in apoptosis. Aging Cell 1: 112-116, 2002.
50. Lunghi P, Giuliani N, Mazzera L, Lombardi G, Ricca M, Corradi A, Cantoni AM, Salvatore L, Riccioni R and Costanzo A: Targeting MEK/MAPK signal transduction module potentiates ATO-induced apoptosis in multiple myeloma cells through multiple signaling pathways. Blood 112: 2450-2462, 2008.
51. Mansouri A, Ridgway LD, Korapati AL, Zhang Q, Tian L, Wang Y, Siddik ZH, Mills GB and Claret FX: Sustained activation of JNK/p38 MAPK pathways in response to cisplatin leads to Fas ligand induction and cell death in ovarian carcinoma cells. J Biol Chem 278: 19245-19256, 2003.